Clinical Trials Browser

Interventional × Prostatic Neoplasms × Colony-Stimulating Factors × Clear all

NCT00064129 2020-07-30

Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT00274287 2019-03-28

GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere

Phase 2 Completed

15 enrolled 12 charts

Prostatic Neoplasms

NCT00477087 2017-11-29

Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

Phase 2 Terminated

10 enrolled 10 charts

Prostatic Neoplasms